PGP9.5 expression in human tumors: A tissue microarray study on 13,920 tumors from 120 different tumor entities

The protein gene product 9.5 (PGP9.5), also termed ubiquitin C-terminal hydrolase L1 (UCH-L1) is an important component of the ubiquitination/deubiquitination system and plays a role in axonal transport. To comprehensively determine PGP9.5 expression in neoplastic tissues, a tissue microarray contai...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pathology, research and practice research and practice, 2024-12, Vol.264, p.155676, Article 155676
Hauptverfasser: Scherzai, Sekander, Lennartz, Maximilian, Jacobsen, Frank, Viehweger, Florian, Dum, David, Menz, Anne, Schlichter, Ria, Hinsch, Andrea, Höflmayer, Doris, Hube-Magg, Claudia, Fraune, Christoph, Bernreuther, Christian, Lebok, Patrick, Weidemann, Sören, Sauter, Guido, Clauditz, Till S., Krech, Till, Marx, Andreas H., Simon, Ronald, Steurer, Stefan, Burandt, Eike, Gorbokon, Natalia, Minner, Sarah
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The protein gene product 9.5 (PGP9.5), also termed ubiquitin C-terminal hydrolase L1 (UCH-L1) is an important component of the ubiquitination/deubiquitination system and plays a role in axonal transport. To comprehensively determine PGP9.5 expression in neoplastic tissues, a tissue microarray containing 13,920 samples from 120 different tumor types and subtypes was analyzed by immunohistochemistry (IHC). PGP9.5 immunostaining was found in 109 of 120 tumor categories, 87 of which contained at least one strongly positive case. PGP9.5 positivity was most seen in neuronal and neuroendocrine neoplasms (50–100 %), germ cell neoplasms (28–84 %), sarcomas and carcinosarcomas (up to 91 %), and in mesotheliomas (58–83 %). In clear cell RCC (renal cell carcinomas), strong PGP9.5 staining was associated with high ISUP (International Society of Urological Pathology) grade (p
ISSN:0344-0338
1618-0631
1618-0631
DOI:10.1016/j.prp.2024.155676